Brii Biosciences Limited
BRIBF
$0.2406
$0.00944.07%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.82M | -15.90M | -19.37M | -19.54M | 1.04M |
| Total Depreciation and Amortization | 167.20K | 168.00K | 417.20K | 420.80K | 467.90K |
| Total Amortization of Deferred Charges | 27.90K | 28.10K | -- | -- | 27.90K |
| Total Other Non-Cash Items | 8.91M | 8.95M | 3.36M | 3.39M | -9.82M |
| Change in Net Operating Assets | -3.50M | -3.52M | -- | -- | -8.36M |
| Cash from Operations | -10.22M | -10.27M | -15.59M | -15.72M | -16.64M |
| Capital Expenditure | -171.20K | -172.00K | -52.80K | -53.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.03M | 35.20M | 27.25M | 27.49M | 17.25M |
| Cash from Investing | 34.86M | 35.03M | 27.20M | 27.43M | 17.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.70M | -1.70M | -1.74M | -1.74M | -2.42M |
| Issuance of Common Stock | 5.00K | 5.00K | 21.50K | 21.50K | 24.50K |
| Repurchase of Common Stock | -110.00K | -110.00K | -- | -- | -581.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -688.50K | -688.50K | -494.50K | -494.50K | -120.00K |
| Cash from Financing | -346.40K | -348.10K | -305.30K | -308.00K | -429.00K |
| Foreign Exchange rate Adjustments | -164.50K | -165.30K | 200.80K | 202.50K | -31.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.13M | 24.24M | 11.50M | 11.60M | 149.30K |